Section Arrow
RCKT.NASDAQ
- Rocket Pharmaceuticals
Quotes are at least 15-min delayed:2024/10/31 18:39 EDT
Last
 16.65
-0.32 (-1.89%)
Day High 
17.08 
Prev. Close
16.97 
1-M High
18.89 
Volume 
671.54K 
Bid
16.57
Ask
16.66
Day Low
16.48 
Open
16.9 
1-M Low
15.975 
Market Cap 
1.54B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 17.62 
20-SMA 17.23 
50-SMA 18.3 
52-W High 32.525 
52-W Low 15.975 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.77/-2.78
Enterprise Value
1.57B
Balance Sheet
Book Value Per Share
4.23
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABElevai Labs0.059-0.0339-36.49%-- 
AVTEAerovate Therapeutics2.46+0.27+12.33%-- 
ENSCEnsysce Biosciences0.5754-0.0629-9.85%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.1445-0.0099-6.41%-- 
GLYCGlycoMimetics0.4069-0.0496-10.87%-- 
Quotes are at least 15-min delayed:2024/10/31 18:39 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.